OSL.AX
Price:
$0.005
Market Cap:
$23.03M
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.[Read more]
Industry
Medical - Devices
IPO Date
2005-08-15
Stock Exchange
ASX
Ticker
OSL.AX
According to OncoSil Medical Limited’s latest financial reports and current stock price. The company's current ROE is -280.65%. This represents a change of 156.69% compared to the average of -109.33% of the last 4 quarters.
The mean historical ROE of OncoSil Medical Limited over the last ten years is -84.12%. The current -280.65% ROE has changed 233.64% with respect to the historical average. Over the past ten years (40 quarters), OSL.AX's ROE was at its highest in in the March 2009 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -147.38%.
Average
-84.12%
Median
-74.74%
Minimum
-251.53%
Maximum
-19.46%
Discovering the peaks and valleys of OncoSil Medical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 358.40%
Maximum Annual ROE = -19.46%
Minimum Annual Increase = -75.75%
Minimum Annual ROE = -251.53%
Year | ROE | Change |
---|---|---|
2024 | -251.53% | 119.10% |
2023 | -114.80% | 19.47% |
2022 | -96.09% | 7.72% |
2021 | -89.20% | 358.40% |
2020 | -19.46% | -75.75% |
2019 | -80.25% | 70.61% |
2018 | -47.04% | -32.05% |
2017 | -69.23% | 115.01% |
2016 | -32.20% | -22.15% |
2015 | -41.36% | -6.71% |
The current ROE of OncoSil Medical Limited (OSL.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-154.14%
5-year avg
-114.22%
10-year avg
-84.12%
OncoSil Medical Limited’s ROE is greater than ImpediMed Limited (-43.15%), less than Opthea Limited (520.65%), greater than Prescient Therapeutics Limited (-40.50%), greater than Orthocell Limited (-214.01%), greater than Patrys Limited (-83.38%),
Company | ROE | Market cap |
---|---|---|
-43.15% | $107.29M | |
520.65% | $923.44M | |
-40.50% | $38.66M | |
-214.01% | $340.38M | |
-83.38% | $6.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSil Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OncoSil Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OncoSil Medical Limited's ROE?
How is the ROE calculated for OncoSil Medical Limited (OSL.AX)?
What is the highest ROE for OncoSil Medical Limited (OSL.AX)?
What is the 3-year average ROE for OncoSil Medical Limited (OSL.AX)?
What is the 5-year average ROE for OncoSil Medical Limited (OSL.AX)?
How does the current ROE for OncoSil Medical Limited (OSL.AX) compare to its historical average?